![](https://investorshub.advfn.com/uicon/613762.png?cb=1495247035)
Saturday, December 15, 2018 10:18:05 AM
Will placentas from different donors need to be kept separately? Are they sorted and segmented based on HLA?
How do we know that the 'selective nature' of efficacy based on 'sickest receive greatest benefit' is a function of the miracle of the placenta VS. pluristem spin on HLA matching, antibodies yet undescribed, etc. etc.
Lots of questions...
Will the studies performed from single placenta now be required to use 'different' placentas, mixed, to evaluate for greater efficacy/safety in other indications??
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM